Sinopharm Holding

Shanghai, China Founded: 2003 • Age: 23 yrs Listed
Chinese medicines are manufactured and distributed by Sinopharm.

About Sinopharm Holding

Sinopharm Holding is a publicly listed company based in Shanghai (China) founded in 2003. Chinese medicines are manufactured and distributed by Sinopharm. The company has 61,694 employees. Its chief executive, as recorded, is Li Zhiming. Its website sinopharmholding.com draws about 117 thousand monthly visits. Its focus areas include Pharmaceutical Distributors, Alternative Medicines and Traditional Chinese Medicines. Its competitors include Tasly, Methuselah Medical Technology and Yixintang Pharmaceutical; 2 of its 3 listed competitors have raised funding.

Company details

Sinopharm was established in 2003 in Shanghai, China, within the pharmaceutical sector. Focus is placed on the production and distribution of traditional Chinese medicines. Operations encompass manufacturing processes and supply chain management for domestic and international markets. The company is led by CEO Li Zhiming, with activities centered in the Asia-Pacific region to support healthcare needs through established networks.

  • Headquarters Shanghai, China
  • Employees 61,694
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website sinopharmholding.com
Key Metrics
  • Employee Count
    61,694

People of Sinopharm Holding

1 people are tracked at Sinopharm Holding (1 in leadership); the tracked headcount is 61,694.

NameRoleGroup
Li Zhiming
CEOLeadership
Premium access

Complete people profiles for Sinopharm Holding

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Sinopharm Holding

Sinopharm Holding has 3 listed competitors in our database, 2 of them funded. They include Tasly, Methuselah Medical Technology and Yixintang Pharmaceutical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tasly.com1994Tianjin, China$84.5M
Traditional Chinese medicines are manufactured and distributed globally.
mn969.com2012Shanghai, China$41.39M
Medical nutrition products are manufactured and supplied internationally.
hx8886.com2000Kunming, China
Chinese pharmaceutical products are distributed and retailed by Yixintang Pharmaceutical.
Premium access

Detailed competitors of Sinopharm Holding

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Sinopharm Holding

The website of Sinopharm Holding (sinopharmholding.com) receives about 117.2K visits a month and ranks #231,349 among all websites worldwide, #7,669 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    117.2K

    ▼ 7.3% vs previous month

  • Unique visitors
    9.2K

    per month

  • Global rank
    #231,349

    among all websites

  • Category rank
    #7,669

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Sinopharm Holding. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
hisunpharm.com
100%
100.8KView details
sinopharm.com
100%
51.6K#492,192View details
pharmtec.org.cn
pharmtec.org.cn
61%
–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sinopharm Holding

Premium access

Complete news archive for Sinopharm Holding

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sinopharm Holding

Sinopharm Holding was founded in 2003.

Sinopharm Holding is headquartered in Shanghai, China.

Li Zhiming is the CEO of Sinopharm Holding, as recorded in our data.

Sinopharm Holding has 61,694 employees.

Sinopharm was established in 2003 in Shanghai, China, within the pharmaceutical sector. Focus is placed on the production and distribution of traditional Chinese medicines. Operations encompass manufacturing processes and supply chain management for domestic and international markets. The company is led by CEO Li Zhiming, with activities centered in the Asia-Pacific region to support healthcare needs through established networks.

Sinopharm Holding's top competitors include Tasly, Methuselah Medical Technology and Yixintang Pharmaceutical.

The website of Sinopharm Holding receives about 117 thousand visits a month and ranks #231,349 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available